相关实验视频
Updated: Jun 26, 2026
12:10
Performing Behavioral Tasks in Subjects with Intracranial Electrodes
Published on: October 2, 2014
11.8K
响应神经刺激的电图发作:早期和客观的测量对雪诺巴酸的反应
Sami Aboumatar1, Jay R Gavvala2, Zeenat Jaisani3
1Austin Epilepsy Care Center, Austin, TX, USA.
Epilepsy research
|September 7, 2025
概括
辅助赛诺巴显著减少了先前接受响应性神经刺激 (RNS) 治疗的患者的电图 (ESs) 和临床. RNS电皮图学数据可以客观地评估抗发作药物的治疗疗效.
科学领域:
- 神经科学是一个神经科学.
- 临床神经学 临床神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 响应神经刺激 (RNS) 通过电皮质谱 (ECoG) 提供客观数据来评估抗发作药物 (ASM) 的有效性.
- 塞诺巴是一种用于焦点发作的附加ASM,但其对RNS检测事件 (RDE) 的影响尚未得到充分证实.
研究的目的:
- 评价辅助赛诺巴对RNS检测到的焦点发作 (ESs) 对焦点的成年人的影响.
- 评估RNS ECoG数据与患者在治疗中报告的临床发作频率之间的相关性.
主要方法:
- 在37名具有RNS植入物启动cenobamate的成年人中进行了回顾性多中心观察性研究.
- 来自NeuroPace患者数据管理系统的RDE和电图 (ES) 的分析.
- 从基线到16周的塞诺巴治疗中,ES和临床发作频率的比较.
主要成果:
- 总体ESs (94.4%),ESs ≥50s (100%) 和ESs <50s (100%) 的显著中位数从基线减少.
- 在有可用数据的患者中,每28天临床的中位数减少了72.2%.
- 27%的患者报告了包括头和疲劳在内的不良事件.
结论:
- 在RNS患者中,辅助赛诺巴酸显著减少了电图和临床发作.
- RNS ECoG数据可以作为一个客观的措施来补充临床数据,以评估巴的疗效.
- 这种方法可能为监测RNS植入患者的ASM反应提供一个更广泛的策略.
更多相关视频
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
18.0K
04:51Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
10.2K
相关概念视频
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...